TABLE 6.
ISOTRETINOIN COURSE NUMBER AND LENGTH OF THERAPY | ||||||
---|---|---|---|---|---|---|
LENGTH OF THERAPY | INITIAL COURSE | 2nd COURSE | INITIAL COURSE | 2nd COURSE | INITIAL COURSE | 2nd COURSE |
ALL PATIENTS | FEMALE PATIENTS | MALE PATIENTS | ||||
1 Rx | ||||||
2 Rx | ||||||
3 Rx | ||||||
4 Rx | 4,958 | 13.7% | 2,696 | 11.8% | 2,262 | 15.9% |
5 Rx | 11,237 | 9.6% | 6,220 | 7.4% | 5,017 | 12.3% |
6 Rx | 7,587 | 9.7% | 4,080 | 7.9% | 3,505 | 11.7% |
7 Rx | 2,796 | 10.7% | 1,495 | 8.8% | 1,301 | 12.8% |
8+ Rx | 2,262 | 12.1% | 1,165 | 10.0% | 1,097 | 14.3% |
TOTAL | 28,840 | 10.6% | 15,656 | 8.6% | 13,182 | 13.0% |
Initial course of isotretinoin is aligned to Length of Therapy column. Percentages use initial (1st) course as denominator.
Prescription data obtained from IMS Health